CARMEL,
Ind., May 14, 2024 /PRNewswire/ -- Syra
Health Corp. (NASDAQ: SYRA) ("Syra Health" or the
"Company"), a healthcare technology company with a mission
to improve healthcare by providing innovative services and
technology solutions, announced today that the Company is a
subcontractor for LUKE, a prime contractor on a 10-year
$43 billion Defense Health Agency
(DHA) Indefinite-Delivery, Indefinite-Quantity (IDIQ) contract, for
the Medical Q-Coded Support and Services – Next Generation Program
(MQS2-NG ), to provide medical staffing services at DHA facilities
across the country.
LUKE as part of the unrestricted vendor pool, has been awarded
all areas of responsibility for staffing five Defense Health Agency
labor markets including physicians, nurses, dentists, ancillary
services, and medical support personnel. In support of the
contract's execution, Syra Health will serve as a subcontractor for
LUKE and help perform the required services including providing
contract workers across various healthcare labor categories in
support of mission requirements within DHA hospitals, clinics,
dental facilities, and health activities in the 50 United States,
D.C., Puerto Rico, Guam, and U.S. territories and possessions.
The contract is expected to run from June
2024 until May 31, 2034.
Task orders – some of which are anticipated to be received
before year's end – will determine the portion of contract revenue
for Syra Health.
"We are honored to partner with LUKE in support of the Defense
Health Agency's needs. Staffing of medical roles to ensure
preparedness for those serving our country is vital to our
country's health," said Dr. Deepika
Vuppalanchi, CEO, Syra
Health. "I'm very pleased that Syra Health is being
recognized for our commitment to providing exceptional healthcare
services to federal agencies."
This is Syra Health's second federal government contract
announcement. In addition to operating as a subcontractor for LUKE,
Syra Health is also a subcontractor of Caduceus Healthcare.
ABOUT SYRA HEALTH
Syra Health is a healthcare technology company addressing some
of healthcare's most significant challenges in areas such
as behavioral and mental health, digital health,
and population health, by providing innovative services and
technology solutions. Syra Health's products and services are
centered on prevention, improved access, and affordable care. Syra
Health supplies its solutions to payers, providers, life sciences
organizations, academic institutions, and government. For more
information, please visit www.syrahealth.com.
FORWARD-LOOKING STATEMENTS
Statements in this press release about future expectations,
plans, and prospects, as well as any other statements regarding
matters that are not historical facts, may constitute
"forward-looking statements." These statements include, but are not
limited to, statements relating to the expected use of proceeds,
the Company's operations and business strategy and the Company's
expected financial results. The words "anticipate," "believe,"
"continue," "could," "estimate," "expect," "intend," "may," "plan,"
"potential," "predict," "project," "should," "target," "will,"
"would" and similar expressions are intended to identify
forward-looking statements, although not all forward-looking
statements contain these identifying words. The forward-looking
statements contained in this press release are based on
management's current expectations and are subject to substantial
risks, uncertainty and changes in circumstances. Investors should
read the risk factors set forth in our Form 10-K for the year ended
December 31, 2023, and other periodic
reports filed with the Securities and Exchange Commission. Any
forward-looking statements contained in this press release speak
only as of the date hereof, and, except as required by federal
securities laws, the Company specifically disclaims any obligation
to update any forward-looking statements, whether as a result of
new information, future events, or otherwise.
For more information, please contact:
For Media Inquiries:
Christine
Drury
Communications and Marketing Director
Syra Health
463-345-5180
christined@syrahealth.com
For Investor Inquiries:
Ben
Shamsian
Vice President
Lytham Partners, LLC
646-829-9701
shamsian@lythampartners.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/syra-health-to-subcontract-for-luke-on-a-defense-health-agency-contract-valued-at-43-billion-302144272.html
SOURCE Syra Health
